Cargando…

Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation

The use of cyclodextrins as drug nano-carrier systems for drug delivery is gaining importance in the pharmaceutical industry due to the interesting pharmacokinetic properties of the resulting inclusion complexes. In the present work, complexes of the anti-cancer alkaloids camptothecin and luotonin A...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Ruiz, Víctor, Cores, Ángel, Martín-Cámara, Olmo, Orellana, Karen, Cervera-Carrascón, Víctor, Michalska, Patrycja, Olives, Ana I., León, Rafael, Martín, M. Antonia, Menéndez, J. Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537677/ https://www.ncbi.nlm.nih.gov/pubmed/34683902 http://dx.doi.org/10.3390/pharmaceutics13101609

Ejemplares similares

Bisavenathramide Analogues as Nrf2 Inductors and Neuroprotectors in In Vitro Models of Oxidative Stress and Hyperphosphorylation
por: Cores, Ángel, et al.
Publicado: (2021)

Fluorescence Sensors Based on Hydroxycarbazole for the Determination of Neurodegeneration-Related Halide Anions
por: González-Ruiz, Víctor, et al.
Publicado: (2022)

Enantioselective Synthesis and Pharmacological Evaluation of Aza-CGP37157–Lipoic Acid Hybrids for the Treatment of Alzheimer’s Disease
por: Cores, Ángel, et al.
Publicado: (2022)

Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects
por: Sarabia-Vallejo, Álvaro, et al.
Publicado: (2023)

B-Ring-Aryl Substituted Luotonin A Analogues with a New Binding Mode to the Topoisomerase 1-DNA Complex Show Enhanced Cytotoxic Activity
por: González-Ruiz, Víctor, et al.
Publicado: (2014)

Curcumin-Piperlongumine Hybrids with a Multitarget Profile Elicit Neuroprotection in In Vitro Models of Oxidative Stress and Hyperphosphorylation
por: Cores, Ángel, et al.
Publicado: (2021)

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
por: Matias-Barrios, Victor M., et al.
Publicado: (2021)

DNA topoisomerases as molecular targets for anticancer drugs
por: Buzun, Kamila, et al.
Publicado: (2020)

NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
por: Cores, Ángel, et al.
Publicado: (2020)

Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
por: Jain, Chetan Kumar, et al.
Publicado: (2017)

When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration
por: Michalska, Patrycja, et al.
Publicado: (2020)

Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment
por: Ben Mihoub, Amina, et al.
Publicado: (2018)

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
por: Molinaro, Caroline, et al.
Publicado: (2020)

Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer’s disease
por: Gameiro, Isabel, et al.
Publicado: (2017)

Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites.
por: Frantz, C E, et al.
Publicado: (1996)

Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II
por: Hawtin, Rachael E., et al.
Publicado: (2010)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

Antioxidants as Molecular Probes: Structurally Novel Dihydro-m-Terphenyls as Turn-On Fluorescence Chemodosimeters for Biologically Relevant Oxidants
por: González-Ruiz, Víctor, et al.
Publicado: (2020)

The Role of the MAPK Signaling, Topoisomerase and Dietary Bioactives in Controlling Cancer Incidence
por: Selim, Khaled A., et al.
Publicado: (2017)

Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery
por: Varan, Gamze, et al.
Publicado: (2017)

Rescuing compound bioactivity in a secondary cell-based screening by using γ-cyclodextrin as a molecular carrier
por: Claveria-Gimeno, Rafael, et al.
Publicado: (2015)

Electrospun Fibers of Cyclodextrins and Poly(cyclodextrins)
por: Costoya, Alejandro, et al.
Publicado: (2017)

Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents
por: Drwal, Malgorzata N., et al.
Publicado: (2011)

On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
por: Wu, Chyuan-Chuan, et al.
Publicado: (2013)

A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents
por: Okoro, Cosmas O., et al.
Publicado: (2023)

TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling
por: Heiniö, Camilla, et al.
Publicado: (2020)

Cyclodextrins, Natural Compounds, and Plant Bioactives—A Nutritional Perspective
por: Wüpper, Svenja, et al.
Publicado: (2021)

Bioactive peptides for anticancer therapies
por: Zhang, Yehao, et al.
Publicado: (2023)

Potential use of Folate-appended Methyl-β-Cyclodextrin as an Anticancer Agent
por: Onodera, Risako, et al.
Publicado: (2013)

2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent
por: Yokoo, Masako, et al.
Publicado: (2015)

Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins
por: De Gaetano, Federica, et al.
Publicado: (2022)

Characterization of Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications
por: Eid, Eltayeb E. M., et al.
Publicado: (2023)

Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
por: Xu, Yang, et al.
Publicado: (2015)

A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity
por: Li, Zhi-Ying, et al.
Publicado: (2021)

Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade
por: Dey, Dipta, et al.
Publicado: (2022)

Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems—A Pharmaceutical Perspective
por: Boczar, Dariusz, et al.
Publicado: (2022)

Influence of Complexation with β- and γ-Cyclodextrin on Bioactivity of Whey and Colostrum Peptides
por: Halavach, Tatsiana M., et al.
Publicado: (2023)

Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1
por: Havunen, Riikka, et al.
Publicado: (2021)

Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease
por: Duarte, Pablo, et al.
Publicado: (2022)

The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy
por: Matias-Barrios, Victor M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_24c1h3ris291rknf1imf65o0im